Literature DB >> 1590319

Steatohepatitis and fatal hepatic failure after biliopancreatic diversion.

I S Grimm1, W Schindler, O Haluszka.   

Abstract

Steatohepatitis and hepatic failure are well known complications of jejunoileal bypass, an operation that has been abandoned as a treatment for severe obesity because of its potential for adverse metabolic consequences. Biliopancreatic diversion is a novel operation designed to avoid the harmful effects of jejunoileal bypass. Although it has not gained wide acceptance, this procedure is being advocated by some surgeons as a safe and effective treatment for severe obesity. Published reports indicate that liver histology generally remains stable or improves after biliopancreatic diversion. We present a patient who developed steatohepatitis and subsequently died in hepatic failure after this operation. Severe liver disease should be added to the list of complications that may follow biliopancreatic diversion.

Entities:  

Mesh:

Year:  1992        PMID: 1590319

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis.

Authors:  Tarsila Ribeireiro; James Swain; Michael Sarr; Michael Kendrick; Florencia Que; Schuyler Sanderson; Anuradha Krishnan; Kimberly Viker; Kymberly Watt; Michael Charlton
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

2.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 3.  The effect of bariatric surgeries on nonalcoholic fatty liver disease.

Authors:  Mazen Hassanian; Amnah Al-Mulhim; Atheer Al-Sabhan; Shaden Al-Amro; Fahad Bamehriz; Ayman Abdo; Hisham Al Khalidi; Tamader A Aldoheyan
Journal:  Saudi J Gastroenterol       Date:  2014 Sep-Oct       Impact factor: 2.485

4.  Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery.

Authors:  Toby N Weingarten; James M Swain; Michael L Kendrick; Michael R Charlton; Brent J Schroeder; Robert E Citrowske Lee; Bradly J Narr; Tarsila C R Ribeiro; Darrell R Schroeder; Juraj Sprung
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

Review 5.  Nonalcoholic fatty liver disease.

Authors:  Z M Younossi
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

Review 6.  Update on obesity surgery.

Authors:  Dan Eisenberg; Andrew-J Duffy; Robert-L Bell
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

Review 7.  Biliopancreatic diversion in the surgical treatment of morbid obesity.

Authors:  Robrecht H G G Van Hee
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

8.  Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet.

Authors:  Naoki Tanaka; Shogo Takahashi; Zhong-Ze Fang; Tsutomu Matsubara; Kristopher W Krausz; Aijuan Qu; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2014-08-29

9.  Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

Authors:  H C Pinto; A Baptista; M E Camilo; A Valente; A Saragoça; M C de Moura
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

10.  Liver failure in an obese middle-aged woman after biliointestinal bypass.

Authors:  Dolores Sgambato; Gaetano Cotticelli; Ilario de Sio; Annalisa Funaro; Anna Del Prete; Chiara de Sio; Lorenzo Romano; Alessandro Federico; Antonietta Gravina; Agnese Miranda; Carmelina Loguercio; Marco Romano
Journal:  World J Clin Cases       Date:  2013-04-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.